These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 10866916
1. Carbon dioxide absorbents containing potassium hydroxide produce much larger concentrations of compound A from sevoflurane in clinical practice. Yamakage M, Yamada S, Chen X, Iwasaki S, Tsujiguchi N, Namiki A. Anesth Analg; 2000 Jul; 91(1):220-4. PubMed ID: 10866916 [Abstract] [Full Text] [Related]
2. Compound A concentrations during low-flow sevoflurane anesthesia correlate directly with the concentration of monovalent bases in carbon dioxide absorbents. Higuchi H, Adachi Y, Arimura S, Kanno M, Satoh T. Anesth Analg; 2000 Aug; 91(2):434-9. PubMed ID: 10910864 [Abstract] [Full Text] [Related]
3. Compound A concentration in the circle absorber system during low-flow sevoflurane anesthesia: comparison of Drägersorb Free, Amsorb, and Sodasorb II. Kobayashi S, Bito H, Obata Y, Katoh T, Sato S. J Clin Anesth; 2003 Feb; 15(1):33-7. PubMed ID: 12657409 [Abstract] [Full Text] [Related]
4. Absorbents differ enormously in their capacity to produce compound A and carbon monoxide. Stabernack CR, Brown R, Laster MJ, Dudziak R, Eger EI. Anesth Analg; 2000 Jun; 90(6):1428-35. PubMed ID: 10825335 [Abstract] [Full Text] [Related]
5. Amsorb Plus and Drägersorb Free, two new-generation carbon dioxide absorbents that produce a low compound A concentration while providing sufficient CO2 absorption capacity in simulated sevoflurane anesthesia. Kobayashi S, Bito H, Morita K, Katoh T, Sato S. J Anesth; 2004 Jun; 18(4):277-81. PubMed ID: 15549470 [Abstract] [Full Text] [Related]
6. Only carbon dioxide absorbents free of both NaOH and KOH do not generate compound A during in vitro closed-system sevoflurane: evaluation of five absorbents. Versichelen LF, Bouche MP, Rolly G, Van Bocxlaer JF, Struys MM, De Leenheer AP, Mortier EP. Anesthesiology; 2001 Sep; 95(3):750-5. PubMed ID: 11575550 [Abstract] [Full Text] [Related]
7. Lack of degradation of sevoflurane by a new carbon dioxide absorbent in humans. Mchaourab A, Arain SR, Ebert TJ. Anesthesiology; 2001 Jun; 94(6):1007-9. PubMed ID: 11465591 [Abstract] [Full Text] [Related]
8. Comparison of Amsorb, sodalime, and Baralyme degradation of volatile anesthetics and formation of carbon monoxide and compound a in swine in vivo. Kharasch ED, Powers KM, Artru AA. Anesthesiology; 2002 Jan; 96(1):173-82. PubMed ID: 11753018 [Abstract] [Full Text] [Related]
9. Compound A and carbon monoxide production from sevoflurane and seven different types of carbon dioxide absorbent in a patient model. Keijzer C, Perez RS, de Lange JJ. Acta Anaesthesiol Scand; 2007 Jan; 51(1):31-7. PubMed ID: 17096668 [Abstract] [Full Text] [Related]
14. [Low alkali-hydroxide content in soda limes does not lead to reduction of compound A formation from sevoflurane during low-flow anesthesia]. Reichle FM, Conzen P, Czerner S, Gröger G, Peter K. Anaesthesist; 2001 Mar; 50(3):155-61. PubMed ID: 11315487 [Abstract] [Full Text] [Related]
15. Sevoflurane low-flow anaesthesia: best strategy to reduce Compound A concentration. Di Filippo A, Marini F, Pacenti M, Dugheri S, Focardi L, Novelli GP. Acta Anaesthesiol Scand; 2002 Sep; 46(8):1017-20. PubMed ID: 12190805 [Abstract] [Full Text] [Related]